Health Care & Life Sciences » Pharmaceuticals | Cheil Bio Co. Ltd.

Cheil Bio Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
38,365
39,534
34,980
35,824
27,987
Cost of Goods Sold (COGS) incl. D&A
34,562
35,031
28,956
29,301
21,813
Gross Income
3,803
4,502
6,023
6,522
6,174
SG&A Expense
3,541
3,469
4,971
5,670
5,033
EBIT
251
1,020
1,039
825
1,113
Unusual Expense
-
24
24
34
22
Non Operating Income/Expense
86
149
39
177
427
Interest Expense
75
62
54
29
14
Pretax Income
350
1,149
1,088
1,268
964
Income Tax
9
194
236
254
174
Consolidated Net Income
359
956
852
1,014
789
Net Income
359
956
852
1,014
789
Net Income After Extraordinaries
359
956
852
1,014
789
Net Income Available to Common
359
956
852
1,014
789
EPS (Basic)
31.76
85.84
75.00
68.00
55.00
Basic Shares Outstanding
11
11
11
15
14
EPS (Diluted)
32.09
85.47
75.47
67.60
54.73
Diluted Shares Outstanding
11
11
11
15
14
EBITDA
594
1,387
1,448
1,222
1,482
Other Operating Expense
10
14
13
27
28
Non-Operating Interest Income
88
67
117
329
314

About Cheil Bio Co.

View Profile
Address
131 Sandan-ro 83 beon-gil
Ansan-si GY 15605
Korea, Republic Of
Employees -
Website http://www.cheilbio.com
Updated 09/14/2018
Cheil Bio Co., Ltd. engages in the production and sale of veterinary products for pigs, cattle, chicken, cow, and aquatic animals. Its products include veterinary pharmaceuticals, feed additives, and diagnostic kits. The company was founded on January 1, 1977 and is headquartered in Ansan-si, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.